About the Company
Phio Pharmaceuticals Corp. is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) therapeutic platform. The Company's efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform with utility in immune cells and the tumor micro-environment. Our goal is to develop powerful INTASYL therapeutic compounds that can weaponize immune effector cells to overcome tumor immune escape, thereby providing patients a powerful new treatment option that goes beyond current treatment modalities.
Employees
10
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PHIO News
Phio Pharmaceuticals Corp (PHIO) Stock: A Value Analysis
Bitterman Robert J, the President & CEO of Phio Pharmaceuticals Corp, purchase 1,000 shares at $2.84 during a trade that took place back on Jul 01 ’23, which means that Bitterman Robert J is holding ...
Why Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?
Phio Pharmaceuticals unveils findings on PH-762, a promising candidate for cancer therapy. Discover its rapid cell uptake and ...
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
Injection in murine tumors shows the compound is well tolerated -Studies support ongoing clinical trial of PH-762 as a ...
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
Phio’s lead clinical product candidate, PH-762, is the subject of three new dermatological postersMARLBOROUGH, Mass., April ...
PHIO Stock Earnings: Phio Pharma Beats EPS for Q4 2023
PHIO stock results show that Phio Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard ...
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Hibbett, Inc. HIBB rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports ...
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected ...
Buy Rating Justified by Strong Market Acceptance of Phathom Pharmaceuticals’ V oquezna
In a report released today, Joseph Stringer from Needham maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report), ...
Loading the latest forecasts...